The intricate molecular landscape of cancer pathogenesis continues to captivate
researchers worldwide, with Circular RNAs (circRNAs) emerging as pivotal players in the …

Compared with postoperative adjuvant therapy, neoadjuvant therapy has more potential
advantages, such as decreasing tumor stage, killing micrometastatic cells. Because of these …

Objective In view of the high incidence and mortality of esophageal cancer, the latest
statistical data on the disease burden of esophageal cancer can provide strategies for …

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant
tumors. Ferroptosis is a new form of regulated cell death and targeting ferroptosis provides a …

Background Esophageal cancer is one of the most unknown and deadliest cancers in the
world. Although recent studies have identified some mutations linked to the development of …

Background Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with no
clinically ideal biomarkers for early diagnosis. The objective of this study was to develop and …

Background Esophageal squamous cell carcinoma (ESCC) is highly prevalent and has a
high mortality rate. Traditional diagnostic methods, such as imaging examinations and blood …

Cancer is a multifactorial pathological condition characterized by uncontrolled cellular
proliferation, genomic instability, and evasion of regulatory mechanisms. It arises from the …

Background Esophageal squamous cell carcinoma (ESCC) is a deadly type of esophageal
cancer. Programmed cell death (PCD) is an important pathway of cellular self-extermination …

As a highly invasive carcinoma, esophageal cancer (EC) was the eighth most prevalent
malignancy and the sixth leading cause of cancer-related death worldwide in 2020 …